Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Clinical trial NCT05145959 · UNKNOWN
Trial details
- NCT number
- NCT05145959
- Sponsor
- Massachusetts Eye and Ear Infirmary
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.